5,075
Participants
Start Date
May 1, 2006
Primary Completion Date
January 1, 2007
Study Completion Date
July 31, 2007
Adjuvanted pandemic influenza candidate vaccine
2 doses, intramuscular injection
Fluarix
One intramuscular injection
Placebo
One intramuscular injection
GSK Investigational Site, Berlin
GSK Investigational Site, Tallinn
GSK Investigational Site, Berlin
GSK Investigational Site, Caen
GSK Investigational Site, Berlin
GSK Investigational Site, Lagord
GSK Investigational Site, Schwerin
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Marid
GSK Investigational Site, Madrid
GSK Investigational Site, Hanover
GSK Investigational Site, Nantes
GSK Investigational Site, Valencia
GSK Investigational Site, Valencia
GSK Investigational Site, Tartu
GSK Investigational Site, Witten
GSK Investigational Site, Paris
GSK Investigational Site, Rouen
GSK Investigational Site, Munich
GSK Investigational Site, Munich
GSK Investigational Site, Poitiers
GSK Investigational Site, Regensburg
GSK Investigational Site, Würzburg
GSK Investigational Site, Kazan'
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Yekaterinburg
GSK Investigational Site, Novokuznetsk
GSK Investigational Site, Dresden
GSK Investigational Site, Leipzig
GSK Investigational Site, Leipzig
GSK Investigational Site, Rotterdam
GSK Investigational Site, Rotterdam
GSK Investigational Site, Saratov
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Eskilstuna
GSK Investigational Site, Stockholm
Lead Sponsor
GlaxoSmithKline
INDUSTRY